Search
Close this search box.

Deprescribing

FDA Regulatory Review: Implications for Evidence-Based Prescribing

January 16, 2024 at 3PM ET | 12PM PT Presenter: Dr. Joseph Ross Description: This webinar, presented by Dr. Joseph Ross (Yale School of Medicine), will provide a brief history of the FDA and prescription drug oversight, describe the evidentiary standards to secure FDA approval for novel drugs, and discuss implications for evidence-based prescribing. DOWNLOAD […]

FDA Regulatory Review: Implications for Evidence-Based Prescribing Read More »

Overcoming challenges in de-implementing low-value care: Routines, asymmetry of outcomes, and psychological reactance

December 19, 2023 at 2PM ET | 11AM PT Presenter: Dr. Christian Helfrich Christian D. Helfrich, MPH, PhD (he/him) is an implementation scientist and core investigator at the Seattle-Denver Center of Innovation for Veteran-Centered and Value-Driven Care. He studies organizational change and implementation science in healthcare, and how to design and evaluate strategies to reduce low-value practices.

Overcoming challenges in de-implementing low-value care: Routines, asymmetry of outcomes, and psychological reactance Read More »

Tackling Deprescribing in Skilled Nursing Facilities​

October 24, 2023 at 2PM ET | 11AM PT Presenter: Sarah Berry Sarah Berry, M.D. is a geriatrician and clinical researcher at the Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife. Her primary research focuses on preventing injuries in older adults including falls, fractures, and adverse medication events. The majority of her clinical and

Tackling Deprescribing in Skilled Nursing Facilities​ Read More »

Strategies to Improve Care in Older Adults with Diabetes: An Integrated Approach with Deprescribing

September 5, 2023 at 2PM ET | 11AM PT Presenter: Dr. Medha Munshi Description: De-prescribing medications in the management of older adults with diabetes requires a nuanced approach. In this webinar, we will discuss re-alignment of diabetes treatment to better describe what is needed for safe and effective management in older adults. We will also discuss effective

Strategies to Improve Care in Older Adults with Diabetes: An Integrated Approach with Deprescribing Read More »

EQUIPPED for Age-Friendly Prescribing in the Emergency Department

July 18, 2023 at 2PM ET | 11AM PT Presenter: Dr. Camille Vaughn Description: Dr. Vaughan discussed the evaluation of the EQUIPPED medication safety program from its beginnings as a single site quality improvement initiative to a cluster-randomized implementation trial. Since 2012, the EQUIPPED program has been implemented in 20 VA medical centers and 5 non-VA health

EQUIPPED for Age-Friendly Prescribing in the Emergency Department Read More »

Results of the MedSafer Study: Deprescribing Trials and Tribulations

April 4, 2023 at 2PM ET | 11AM PT Presenter: Dr. Emily McDonald  Description: Dr. McDonald will present the MedSafer Study which tested a software that guided clinicians through the process of deprescribing for older adults with polypharmacy during an acute care hospitalization. The webinar will present the results of the MedSafer study, the largest randomized

Results of the MedSafer Study: Deprescribing Trials and Tribulations Read More »

Is there a Role for Pharmacoepidemiology in Deprescribing Research?

October 6, 2022   |  12:00 – 1:00 PM Eastern / 9:00 – 10:00 AM Pacific The session, hosted by the International Society for Pharmacoepidemiology (ISPE), will begin with a brief introduction of the topic and the speakers (moderators, 4-5 min, Drs. Andrew Zullo & Daniela Moga) followed by presentations to address: The existing deprescribing landscape (including existing

Is there a Role for Pharmacoepidemiology in Deprescribing Research? Read More »

Deprescribing Interventions: Learnings from an Overview of Systematic Reviews

https://youtu.be/6g5nHveow1Y Rigorous evidence to guide deprescribing is limited, and priorities to inform deprescribing research and practice remain unclear. Further, it is not known if there are medication targets or patient groups that are most likely to yield the greatest benefit in improving outcomes to inform allocation of limited healthcare resources.   This study, funded as part

Deprescribing Interventions: Learnings from an Overview of Systematic Reviews Read More »

Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial

Elizabeth Bayliss, MD, MSPHSenior Investigator, Institute for Health Research, Kaiser Permanente ColoradoProfessor of Family Medicine, University of Colorado School of MedicineIMPACT Health Care Systems (HCS) CoreUSDeN Data and Resources Core Co-LeaderUSDeN Measures Working Group Leader Cynthia Boyd, MD, MPHDirector, Division of Geriatric Medicine and GerontologyProfessor of Medicine, Epidemiology and Health Policy and ManagementJohns Hopkins University

Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial Read More »

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.